ALFA Finder| Management target | Revenue FY30 |
|---|
| Revenue growth | Consolidated revenue up 12.7% YoY; Gurgaon standalone up 15.4%. |
|---|---|
| Margins | EBITDA margin at 21.5%; aiming for 23%+ through operating leverage. |
| Demand visibility | Strong tertiary/quaternary demand; international patients stable despite West Asia conflict. |
| Management confidence | High; MD aggressively targeting 2,000 beds and quaternary care leadership. |
Growth
Revenue grew 12.7% YoY consolidated; net profit surged 48.9% due to improved case mix.
Outlook
Targeting 2,000 operational beds by FY30 with 23%+ EBITDA margins at mature facilities.
Risks
Expansion capex of ₹800Cr+ plus ₹250Cr deposit for Vimhans poses significant near-term leverage risks.
Last quarter's promises, checked
Delivered
- Guided 15-17% revenue growth → delivered 15.4% (= BEAT)
- Guided Raipur Q1 FY27 launch → delivered Operationalized Q1 FY27 (= BEAT)
- Guided 20%+ Gurgaon EBITDA margin → delivered 21.5% (= BEAT)
Partly delivered
- Guided 70%+ Gurgaon occupancy by Q2 → delivered 64.6% currently (= PARTIAL)
Earnings Call Transcript filed with BSE, NSE: ARTEMISMED. Summary written with AI assistance from the document.
Artemis Medicare Services Ltd: key numbers
- Share price
- ₹313.50
- Market cap
- ₹4,963 Cr
- Revenue (annual)
- ₹1,081 Cr
- Net profit (annual)
- ₹103.6 Cr
- P/E (TTM)
- 43.3×Sector 54.5×
- Promoter holding
- 58.39%+0.00% QoQ
- FII holding
- 12.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Artemis Medicare Services Ltd
All →Artemis Medicare Services Earnings Call Transcript: Key Takeaways
Artemis reports strong growth led by Gurgaon's record EBITDA and new Raipur operations. Aggressive expansion plans aim for 2,000 beds within five years despite regulatory drug pricing concerns.
Artemis Medicare Services Other Announcement
Artemis Medicare filed CARE Ratings' quarterly monitoring report on its Rs.330 crore preferential issue. It reports no deviation, with proceeds used as per the disclosed objects.
Artemis Medicare Services Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue INR 31,104 Lacs (+13.2% YoY); adj. EBITDA INR 7,150 Lacs (+22.7%, 23.3% margin); PAT INR 3,110 Lacs (+3.7%). Raipur ramp-up dilutes reported margins.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Artemis Medicare Services Q2 FY27 Results: Net Profit ₹31.1 Cr, Up 3.7% YoY
Artemis Medicare Services Ltd reported revenue from operations of ₹311 Cr (+13.2% YoY) and net profit of ₹31.1 Cr (+3.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹31.1 Cr · +3.7% YoY
Artemis Medicare Services Board Meeting Date
Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.